-
Dupixent® (dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
13 Sep 2024 16:15 GMT
… payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and …
-
Blue Cross NC ACA customers will experience rate hike in 2025
13 Sep 2024 14:23 GMT
… will offer a broad network health maintenance organization plan, Blue Care, in all …
-
A look at Cleveland Clinic Akron General's $3.2M pediatrics investment
12 Sep 2024 22:05 GMT
… facility for Health Guard, a health maintenance organization run by Blue Cross …
-
EYLEA HD® (aflibercept) Injection 8 mg Data at EURETINA Reinforce Long-term Durability, Sustained Fluid Control and Safety Profile
11 Sep 2024 11:00 GMT
… payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and …
-
Press Release: Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU
11 Sep 2024 05:20 GMT
… payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and …
-
Dupixent® (dupilumab) Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria (CSU)
11 Sep 2024 05:04 GMT
… payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and …
-
Press Release: Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU
11 Sep 2024 05:05 GMT
… payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and …
-
Dupixent® (dupilumab) Is the First and Only Biologic to Achieve Significant Improvements in Disease Remission and Symptoms in Bullous Pemphigoid (BP) Positive Pivotal Trial
11 Sep 2024 04:59 GMT
… payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and …
-
Press Release: Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study
11 Sep 2024 05:00 GMT
… payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and …
-
Methodist Healthcare Adopts IR-MED’s PressureSafe™ Device for Usability Study: Decision Support Device Aims to Reduce Substantial Healthcare Burden of Pressure Injuries
10 Sep 2024 13:15 GMT
… by Clalit, Israel’s largest health maintenance organization (HMO) and the second largest …